Grufity logo
Grufity logo

Latest Saturn V Capital Management LLC Stock Portfolio

$697Million | No. of Holdings #23

Saturn V Capital Management LLC Performance

2026 Q2+16.11%
YTD+26.17%
2025+79.96%

About Saturn V Capital Management LLC and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Saturn V Capital Management LP reported an equity portfolio of $697.5 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Saturn V Capital Management LP are AMLX, , . The fund has invested 11.9% of it's portfolio in AMYLYX PHARMACEUTICALS INC and 11.8% of portfolio in ALUMIS INC. <br><br> The fund managers got completely rid off COGENT BIOSCIENCES INC (COGT) stocks. They significantly reduced their stock positions in OVID THERAPEUTICS INC (OVID), INVIVYD INC (ADGI) and MONOPAR THERAPEUTICS INC (MNPR). Saturn V Capital Management LP opened new stock positions in TREVI THERAPEUTICS INC (TRVI), SAGIMET BIOSCIENCES INC and VIR BIOTECHNOLOGY INC (VIR). The fund showed a lot of confidence in some stocks as they added substantially to ZURA BIO LTD, CELCUITY INC (CELC) and IMMIX BIOPHARMA INC (IMMX).
Saturn V Capital Management LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$697Million
  as of Aug 14, 2026

Saturn V Capital Management LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Saturn V Capital Management LP made a return of 16.11% in the last quarter. In trailing 12 months, it's portfolio return was 154.08%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
trevi therapeutics inc19,620,600
sagimet biosciences inc11,439,800
vir biotechnology inc7,852,850
New stocks bought by Saturn V Capital Management LLC

Additions

Ticker% Inc.
zura bio ltd183
alto neuroscience inc105
oculis holding ag32.53
celcuity inc31.36
immix biopharma inc26.12
disc medicine inc16.63
candel therapeutics inc14.05
dyne therapeutics inc9.4
Additions to existing portfolio by Saturn V Capital Management LLC

Reductions

Ticker% Reduced
ovid therapeutics inc-84.09
invivyd inc-23.35
monopar therapeutics inc-9.74
alumis inc-8.95
abivax sa-4.39
jazz pharmaceuticals plc-1.24
Saturn V Capital Management LLC reduced stake in above stock

Sold off

Ticker$ Sold
cogent biosciences inc-24,119,200
Saturn V Capital Management LLC got rid off the above stocks

Sector Distribution

Saturn V Capital Management LP has about 59.4% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare59.4
Others39.6

Market Cap. Distribution

Saturn V Capital Management LP has about 5.6% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
Category%
UNALLOCATED39.6
MID-CAP30.8
SMALL-CAP22
LARGE-CAP5.6
MICRO-CAP2.2

Stocks belong to which Index?

About 36.8% of the stocks held by Saturn V Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others63.2
RUSSELL 200036.8
Top 5 Winners (%)%
CADL
candel therapeutics inc
96.8 %
MNPR
monopar therapeutics inc
65.6 %
satellos bioscience inc
38.1 %
AMLX
amylyx pharmaceuticals inc
28.1 %
JAZZ
jazz pharmaceuticals plc
27.3 %
Top 5 Winners ($)$
alumis inc
18.7 M
AMLX
amylyx pharmaceuticals inc
18.2 M
CADL
candel therapeutics inc
16.7 M
MNPR
monopar therapeutics inc
12.4 M
abivax sa
11.6 M
Top 5 Losers (%)%
oculis holding ag
-44.6 %
ADGI
invivyd inc
-29.1 %
CELC
celcuity inc
-7.4 %
zura bio ltd
-0.6 %
Top 5 Losers ($)$
oculis holding ag
-7.6 M
ADGI
invivyd inc
-4.1 M
CELC
celcuity inc
-3.1 M
zura bio ltd
-0.1 M

Saturn V Capital Management LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Saturn V Capital Management LLC

Saturn V Capital Management LP has 23 stocks in it's portfolio. About 75.6% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Saturn V Capital Management LP last quarter.

$697.47MTotal Value
24.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Saturn V Capital Management LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
PHVS
Pharvaris N V

Pharvaris N V

PHVS
Saturn V Capital Management LLC's holding in Pharvaris N V over time
6.52%1,314,120
$45.44M
6.52%
increased 9.38 percentadded
Com
Alumis Inc

Alumis Inc

Saturn V Capital Management LLC's holding in Alumis Inc over time
11.76%2,915,440
$82.04M
11.76%
decreased 8.95 percentreduced
Sponsored Ads
Abivax Sa

Abivax Sa

Saturn V Capital Management LLC's holding in Abivax Sa over time
9.91%518,865
$69.14M
9.91%
decreased 4.39 percentreduced
Com
Disc Medicine Inc

Disc Medicine Inc

Saturn V Capital Management LLC's holding in Disc Medicine Inc over time
5.5%524,730
$38.38M
5.5%
increased 16.63 percentadded
Class A Ord Shs
Zura Bio Ltd

Zura Bio Ltd

Saturn V Capital Management LLC's holding in Zura Bio Ltd over time
1.78%2,101,120
$12.40M
1.78%
increased 183.95 percentadded